Sign up for 30 days of no-obligation access for all the essential news during this critical time -- you'll be able to choose one of our online services as part of your trial: Inside CMS, FDA Week, Health Exchange Alert, Inside Drug Pricing or Inside TeleHealth.


Sanders, Cassidy Lay Out Priorities

Sanders, Cassidy Named Chair, Ranking Member Of Senate Health Panel

Sens. Bernie Sanders (I-VT) and Bill Cassidy (R-LA) on Thursday (Feb. 2) took up the mantle of Senate health committee chair and ranking member, respectively, kicking off a partnership that experts previously told Inside Health Policy will likely maintain the productive dynamic for which the committee is known.

Cassidy Would ‘Entertain’ Need For Food Agency That’s Separate From FDA

Cassidy: Telehealth Providers Should Be Licensed Where They Practice, Reimbursed Less

Latest Pandemic News

CMS: COVID-19 Optional Group Coverage Ends May 11

Uninsured Americans enrolled in the optional Medicaid group offered by select states to cover COVID-19 vaccine, testing and treatments will lose their coverage once the public health emergency ends on May 11 unless the state decides to foot the bill, CMS told Inside Health Policy on Friday (Feb. 3).

More Investment Needed In Pathogen Origins, Scientists Tell Congress

FDA: Patients Can Get Paxlovid, Lagevrio Even With Negative COVID Test

Experts Call For More Focus On Next-Generation COVID-19 Vaccines

GOP Credits House-Passed Bill To End COVID-19 PHE With Forcing Admin’s Hand

More Coverage →

Latest News

LeadingAge is urging policymakers to consider a series of recommendations the group argues would cushion the blow of impending federal staffing minimums for the nursing home sector.

In separate letters sent to CVS and Walgreens, 20 Republican attorneys general warn the companies of the legal repercussions of sending abortion pills through the mail, coming a month after FDA announced it will allow mifepristone -- one of two pills used in the medication abortion regimen -- to be dispensed through certain pharmacies, including retail pharmacies, and will let the drug be prescribed via telehealth and delivered through the mail.

Illinois Democratic Sens. Dick Durbin and Tammy Duckworth have reached out to pharmacy chains Walgreens, CVS and Rite Aid to ask how the federal government can help ensure the stores have access to and can safely and confidentially provide patients with abortion pills now that FDA has cleared the way for pharmacies to get certified to dispense mifepristone -- one of two pills used as part of a medication abortion regimen -- in stores and by mail.

Senate Finance Committee Chair Ron Wyden (D-OR) is pressing CMS on how it will enforce the new drug pricing law’s requirement that drug makers pay rebates when they raise prices faster than the rate of inflation, saying he strongly hopes companies violating the requirement will be “penalized promptly.”

House Energy & Commerce oversight subcommittee Chair Morgan Griffith (R-VA) told Inside Health Policy he has already offered to work with FDA on creating a safe pathway to bring cannabidiol (CBD) products to market, just days after the agency on Jan. 26 said that the current food and dietary supplement frameworks won’t work for CBD, much to the chagrin of cannabis and dietary supplement groups.

The Infectious Diseases Society of America is eyeing the Pandemic and All Hazards Preparedness Act (PAHPA), a must-pass piece of legislation that’s up for reauthorization this year, as a potential vehicle for passing a key antibiotic funding bill that failed to make it into the fiscal 2023 omnibus spending package.

CMS on Wednesday (Feb. 1) projected in the 2024 advance rate notice that Medicare Advantage plans could see a pay bump of around 1% for 2024 – a sharp decrease from the more than 8% pay bump they received for 2023, as well as the 4% increase plans got for 2022. The smaller pay raise is due in part to CMS proposing a revamped risk adjustment model and changes in star ratings that are projected to hurt plan payments.

CMS released Wednesday (Feb. 1) an advance notice of changes to Medicare Part D payment policies plans will need to factor into their operations in 2024, most of which are measures enacted under the Inflation Reduction Act to lower out-of-pocket prescription drug costs for beneficiaries.

The Texas Medical Association is once again suing the Biden administration over its implementation of the No Surprises Act, this time arguing that CMS’ last-minute increase to the fees charged for using the independence dispute resolution process violates the Administrative Procedure Act.